Bayer CropScience (506285) Q4 25/26 earnings summary

Executive summary

• Annual and quarterly financial results for the period ended March 31, 2026, were audited and reviewed, confirming compliance with Indian Accounting Standards and SEBI regulations.

• Financial statements present a true and fair view of net profit and other comprehensive income for the year.

Financial highlights

• Revenue from operations for FY26 was ₹56,750 million, up from ₹54,734 million year-over-year.

• Net profit for FY26 stood at ₹6,892 million, compared to ₹5,680 million in FY25.

• Q4 FY26 revenue was ₹11,008 million, with net profit at ₹1,621 million.

• Earnings per share (EPS) for FY26 was ₹153.35, up from ₹126.38 in FY25.

• Total comprehensive income for FY26 was ₹6,771 million.

Outlook and guidance

• Business is seasonal, and quarterly figures may not represent full-year performance.

• Company continues to monitor the impact of new labour codes and will adjust accounting as needed.